Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Synthesis

Sigma-Aldrich Signs Boronic Acid Deal

by Michael McCoy
October 13, 2008 | A version of this story appeared in Volume 86, Issue 41

Sigma-Aldrich has signed a licensing agreement with the University of Illinois, Urbana-Champaign, allowing it to offer research quantities of boronic acid surrogates for use in Suzuki-Miyaura coupling. The molecules are based on technology discovered by professor Martin D. Burke and coworkers and use the low-cost ligand N-methyliminodiacetic acid (MIDA). According to Sigma, the MIDA-ligated boronic acid building blocks can be employed to construct families of molecules through a single cross-coupling reaction in an iterative process. The company sees the technology aiding drug discovery.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.